Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy

NCT: NCT07455409 · COMPLETED

NCT IDNCT07455409
StatusCOMPLETED
Start Date2019-08-29
Completion2023-08-18

Brief Summary

This study will determine the feasibility and efficacy of a 10-treatment electro-acupuncture (EA) program in subjects with chemotherapy-induced peripheral neuropathy (CIPN). The Investigators hypothesize that EA will be a feasible and effective therapy for CIPN.

Frequently Asked Questions

What is Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy?

Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy is a clinical trial registered under NCT07455409. Current status: COMPLETED.

What is the status of NCT07455409?

The current status of NCT07455409 (Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy) is: COMPLETED.

When did Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy start?

Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy started on 2019-08-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑